Revium Rx (RVRC) Shares Outstanding (2024 - 2026)

Revium Rx (RVRC) posted Shares Outstanding (Entity) of $60.7 million for Q4 2025, up 435.9% sequentially from $11.3 million in Q4 2024, and up 435.9% YoY from $11.3 million in Q4 2024.

Revium Rx (RVRC) Shares Outstanding (2024 - 2026) Analysis & Trends

Revium Rx has reported Shares Outstanding (Entity) for 2 years, with the latest figure at $60.7 million in Q4 2025.

  • Quarterly Shares Outstanding (Entity) rose 435.9% year-over-year to $60.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $60.7 million (up 435.9% YoY) and the FY2025 annual result came in at $60.7 million, up 435.9% from the prior year.
  • Shares Outstanding (Entity) improved to $60.7 million in Q4 2025 per RVRC's latest filing, from $11.3 million in the prior quarter.
  • Over five years, Shares Outstanding (Entity) peaked at $60.7 million in Q4 2025 and troughed at $11.3 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Veeva Systems 39.72 Bn 32.40 Bn 662.02 Mn 163.35 Mn
2 BrightSpring Health Services 12.19 Bn 11.64 Bn 492.75 Mn 206.04 Mn
3 Healthequity 8.79 Bn 8.52 Bn 256.31 Mn 84.41 Mn
4 10x Genomics 7.31 Bn 6.76 Bn 112.50 Mn 129.98 Mn
5 Hinge Health 7.10 Bn 6.71 Bn 183.95 Mn 78.97 Mn
6 MiniMed 5.66 Bn 5.36 Bn 480.00 Mn 256.60 Mn
7 Waystar Holding 4.76 Bn 4.56 Bn 221.99 Mn 191.87 Mn
8 Doximity 4.46 Bn 3.77 Bn 132.93 Mn 182.57 Mn
9 Heartflow 3.66 Bn 3.28 Bn 53.19 Mn 86.40 Mn
10 Revium Rx 101.42 Mn 99.91 Mn - 60.73 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 60.73 Mn
Dec 31, 2025 60.73 Mn
Dec 31, 2024 11.33 Mn